NIAID Adds Biodefense Proteomics Contracts, Bringing Program Funding Up to $90 Million | GenomeWeb

Earlier this month, the National Institute of Allergy and Infectious Diseases awarded two additional five-year contracts for biodefense-related proteomics to groups at Harvard Medical School and Caprion Pharmaceuticals.

Together with five contracts awarded earlier this summer (see PM 7-16-04), these new awards bring the total funding for NIAID-sponsored Biodefense Proteomics Research Centers up to nearly $80 million.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.